Jae-Kyu Jung

发表

Synthesis and Biological Evaluation of Deoxypreussomerin A and Palmarumycin CP1 and Related Naphthoquinone Spiroketals.

P. Wipf, J. Lazo, Jae-Kyu Jung, 2001 .

Antimitotic actions of a novel analog of the fungal metabolite palmarumycin CP1.

P. Wipf, J. Lazo, B. Day, 2001, The Journal of pharmacology and experimental therapeutics.

Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b.

D. Connolly, C. Sage, Jae-Kyu Jung, 2007, Journal of medicinal chemistry.

Agonist lead identification for the high affinity niacin receptor GPR109a.

Brian M. Smith, D. Connolly, S. Tamura, 2007, Bioorganic & medicinal chemistry letters.

3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice.

D. Connolly, S. Tamura, C. Sage, 2008, Journal of medicinal chemistry.

GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.

J. Tata, S. Colletti, E. Carballo-Jane, 2009, Bioorganic & medicinal chemistry letters.

(1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans.

D. Connolly, J. Knudsen, C. Sage, 2012, Journal of medicinal chemistry.

Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonists.

I. Gaidarov, Michael E. Morgan, K. Whelan, 2015, Bioorganic & medicinal chemistry letters.

GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a.

J. Tata, S. Colletti, E. Carballo-Jane, 2010, Bioorganic & medicinal chemistry letters.

Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).

J. Knudsen, C. Sage, E. Carballo-Jane, 2010, Bioorganic & medicinal chemistry letters.

Discovery of APD371: Identification of a Highly Potent and Selective CB2 Agonist for the Treatment of Chronic Pain.

I. Gaidarov, A. Grottick, Robert M. Jones, 2017, ACS medicinal chemistry letters.

Formal Total Synthesis of (+)-Diepoxin σ

P. Wipf, Jae-Kyu Jung, 2000 .

Formal Total Synthesis of (+)-Diepoxin σ.

P. Wipf, Jae-Kyu Jung, 2001 .

Total Synthesis of Palmarumycin CP1 and (±)-Deoxypreussomerin A

P. Wipf, Jae-Kyu Jung, 1998 .

The Absolute Configuration and Asymmetric Total Synthesis of the CP Molecules (CP-263,114 and CP-225,917, Phomoidrides B and A)

Won Hyung Yoon, K. Nicolaou, P. Baran, 2000 .

Total Synthesis of the Spiroketal Naphthoquinone (±)-Diepoxin σ

P. Wipf, Jae-Kyu Jung, 1999 .

Total Synthesis of the Spiroketal Naphthoquinone (.+-.)-Diepoxin σ.

P. Wipf, Jae-Kyu Jung, 1999 .

Long‐Range Electrostatic Effects in Synthesis: Dipole‐Controlled Nucleophilic Addition to a Naphthoquinone Acetal in Model Studies toward Diepoxin σ

P. Wipf, Jae-Kyu Jung, 1997 .

Total Synthesis of Palmarumycin CP1 and (.+-.)-Deoxypreussomerin A.

P. Wipf, Jae-Kyu Jung, 1998 .

Synthesis and Biological Evaluation of Deoxypreussomerin A and Palmarumycin CP1 and Related Naphthoquinone Spiroketals.

P. Wipf, J. Lazo, Jae-Kyu Jung, 2001 .

Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonists.

I. Gaidarov, Michael E. Morgan, K. Whelan, 2015, Bioorganic & medicinal chemistry letters.